We examined the mechanisms that maintain stable renal tissue PO2 during moderate renal ischemia, when changes in renal oxygen delivery (Ḋ O2) and consumption (V O2) are mismatched. When renal artery pressure (RAP) was reduced progressively from 80 to 40 mmHg, V O2 (Ϫ38 Ϯ 7%) was reduced more than Ḋ O2 (Ϫ26 Ϯ 4%). Electrical stimulation of the renal nerves (RNS) reduced Ḋ O2 (Ϫ49 Ϯ 4% at 2 Hz) more than V O2 (Ϫ30 Ϯ 7% at 2 Hz). Renal arterial infusion of angiotensin II reduced Ḋ O2 (Ϫ38 Ϯ 3%) but not V O2 (ϩ10 Ϯ 10%). Despite mismatched changes in Ḋ O2 and V O2, renal tissue PO2 remained remarkably stable at Ն40 mmHg RAP, during RNS at Յ2 Hz, and during angiotensin II infusion. The ratio of sodium reabsorption to V O2 was reduced by all three ischemic stimuli. None of the stimuli significantly altered the gradients in PCO2 or pH across the kidney. Fractional oxygen extraction increased and renal venous PO2 fell during 2-Hz RNS and angiotensin II infusion, but not when RAP was reduced to 40 mmHg. Thus reduced renal V O2 can help prevent tissue hypoxia during mild renal ischemia, but when renal V O2 is reduced less than Ḋ O2, other mechanisms prevent a fall in renal PO2. These mechanisms do not include increased efficiency of renal oxygen
angiotensin II; carbon dioxide; hypoxia; hypotension; oxygen; sympathetic nervous system VARIOUS CONDITIONS ASSOCIATED with protracted decreases in renal perfusion can lead to acute kidney injury (6, 22, 36) . There is also much evidence that tissue hypoxia contributes to the pathogenesis of some forms of acute kidney injury (5) . Thus we require a better understanding of the mechanisms that influence the PO 2 in kidney tissue during ischemia.
In most tissues and organs, such as the heart (11) and skeletal muscle (14) , maintenance of relatively stable tissue PO 2 is achieved mostly through oxygen-sensing mechanisms within the tissue, which, in turn, regulate vascular tone. Such mechanisms allow tissue perfusion [and, so, oxygen delivery (Ḋ O 2 )] to be regulated according to metabolic demand. However, these regulatory mechanisms have relatively little impact in the kidney (17) . For example, in the rabbit kidney, renal blood flow (RBF) is little affected by hypoxemia or hyperoxemia (29) . Maintenance of homeostasis of kidney oxygenation is thought to be achieved chiefly through the "flow-limited" nature of kidney oxygen consumption (V O 2 ) (37) . That is, because most V O 2 by kidney tissue is attributable to sodium reabsorption, which in turn also drives reabsorption of other solutes (20) , renal V O 2 often varies in proportion with glomerular filtration rate (GFR) and, thus, RBF (41) . However, this mechanism can only completely explain maintenance of homeostasis of intrarenal oxygenation if there is no mismatch between changes in oxygen supply (i.e., Ḋ O 2 ) and demand (i.e., V O 2 ).
Filtration fraction can be altered by a range of factors, including the prevailing level of arterial pressure and the state of neurohumoral activation, leading to mismatched changes in renal Ḋ O 2 and V O 2 . For example, reduced renal artery pressure (RAP) often leads to greater reductions in GFR than RBF and, so, reductions in filtration fraction (43) . Similarly, activation of the renal nerves predominantly increases preglomerular resistance, so it is often accompanied by reductions in filtration fraction (27) . In contrast, activation of the renin-angiotensin system predominantly increases postglomerular resistance and, so, increases filtration fraction (10) . Yet, despite these characteristic differences in the renal vascular actions of angiotensin II and renal nerve activation, renal tissue PO 2 remains remarkably stable when either stimulus is employed to induce moderate renal ischemia (29, 39) .
Thus the concept that homeostasis of intrarenal oxygenation during renal ischemia is entirely dependent on reductions in oxygen supply being matched by proportional reductions in oxygen demand is not compatible with established physiological principles. Therefore, in the present study, we tested the hypothesis that additional mechanisms contribute to maintenance of homeostasis of intrarenal oxygenation during renal ischemia. We envisage four potential mechanisms. 1) Increased efficiency of oxygen utilization within the kidney (17) could potentially allow renal V O 2 to fall during renal ischemia, even if GFR and, so, sodium reabsorption are maintained due to increased filtration fraction. 2) Reduced carbon dioxide washout from the renal circulation during ischemia could lead to acidification of blood in vessels supplying oxygen to kidney tissue. The consequent reduction in the affinity of hemoglobin for oxygen (the Bohr effect) (25) could then enhance renal oxygen extraction.
3) The Bohr effect could also come into play if the countercurrent diffusion of carbon dioxide from renal veins to arteries were to increase (12, 26) . 4) Renal oxygen extraction could increase if the countercurrent diffusion of oxygen from arteries to veins in the kidney were to decrease (29, 38) . To examine the potential for these mechanisms to contribute to maintenance of homeostasis of intrarenal oxygenation, we monitored intrarenal oxygenation in anesthetized rabbits during renal ischemia induced by renal nerve stimulation (RNS), angiotensin II infusion, and reduced RAP. These stimuli were chosen because their effects on filtration fraction differ. We also examined responses to renal hyperemia induced by renal arterial infusion of acetylcholine. Renal carbon dioxide washout was assessed indirectly through comparison of arterial and renal venous blood PCO 2 . We reasoned that the impact of ischemia on renal carbon dioxide washout might depend in part on the level of arterial PCO 2 , so one of our protocols (RNS) was performed under hypocapnic conditions, while the effects of angiotensin II and acetylcholine infusion and reduced RAP were examined under normocapnic conditions. We previously reported the effects of angiotensin II and acetylcholine infusion under hypocapnic conditions (29); therefore, we were able to compare our present and previous findings.
MATERIALS AND METHODS

Animals
Male New Zealand White rabbits (n ϭ 33, 2.78 Ϯ 0.04 kg) were studied according to the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. The experiments were approved in advance by the Animal Ethics Committee of the Monash University School of Biomedical Sciences. Three experimental protocols, each employing a within-subject design, were utilized to examine the effects of RNS (protocol 1), renal arterial infusion of angiotensin II and acetylcholine (protocol 2), and graded reductions in RAP (protocol 3).
Preparative Surgery
Catheters were placed in the central arteries and marginal veins of both ears (7) . Rabbits were then anesthetized with pentobarbital sodium (90 -150 mg plus 30 -50 mg/h iv; Sigma Chemical, St. Louis, MO) and artificially ventilated. Throughout the surgery and experiment, extracellular fluid volume was maintained by intravenous infusion (0.15 ml·kg Ϫ1 ·min Ϫ1 ) of a 4:1 mixture of compound sodium lactate and polygeline-electrolyte solution (29) . Body temperature was maintained at 37.0 -38.0°C.
The left kidney was exposed via a flank incision and placed in a cup secured to the operating table. Catheters were placed in the left renal vein and left ureter (8) . For RNS (protocol 1), the (left) renal nerves were cut, and the distal end was placed across a stimulating electrode. For renal arterial infusion of angiotensin II and acetylcholine (protocol 2), the kidney was denervated, and a catheter was placed in the renal artery via the ileolumbar artery (29) . For manipulation of RAP (protocol 3), an inflatable cuff was placed around the aorta upstream of the renal arteries, and a catheter was placed in the femoral artery for measurement of RAP (15) .
RBF was measured using a transit-time ultrasound flow probe (type 2SB, Transonic Systems, Ithaca, NY). Cortical tissue PO 2 was measured using a fluorescence optode with a built-in thermocouple (BF/ OT, 230 m tip diameter; Oxford Optronix, Oxford, UK), the tip of which was placed ϳ2 mm below the cortical surface (29) . For protocol 3, a fluorescence optode was also placed in the renal medulla (9 mm below the cortical surface) and a Clark electrode (50 m tip diameter; Unisense, Aarhus, Denmark) was placed 2 mm below the cortical surface. Cortical and medullary perfusion were also measured in protocol 3 by laser-Doppler flow probes, as we described previously (39 . A 90-min equilibration period was allowed before experimental procedures commenced. Ventilation rate and tidal volume were adjusted so that arterial blood PO 2 was between 90 and 110 mmHg, which resulted in an arterial PCO2 of ϳ20 mmHg in protocol 1 (RNS). We previously documented the effects of renal arterial infusion of angiotensin II and acetylcholine on intrarenal oxygenation under such hypocapnic conditions (29) , so protocols 2 and 3 were conducted under normocapnic conditions (30 -40 mmHg PCO 2), achieved by application of positive end-expiratory pressure.
Measurements
Signals were amplified and digitized as previously described (19) . GFR was measured as inulin clearance. Sodium concentrations in plasma and urine were determined using a Synchron CX5 Clinical System (Beckman-Coulter). Sodium reabsorption was calculated as the difference between sodium excretion and the product of plasma sodium concentration and GFR. Blood gas analysis was performed on 0.5-ml blood samples with use of a blood gas analyzer (ABL 700 series, Radiometer Copenhagen). Renal Ḋ O2 was calculated as the product of RBF and the oxygen content of arterial blood, while V O2 was calculated as the product of RBF and the arterial-venous (A-V) oxygen concentration difference.
Protocol 1: Electrical Stimulation of the Renal Nerves
Protocol 1 (n ϭ 15) consisted initially of four 20-min periods of RNS at 0, 0.5, 1, and 2 Hz. This was followed by two 3-min periods of RNS at 4 and 8 Hz. A final 20-min control period followed a 30-min recovery period. Urine was collected from the left ureter during the final 15 min of each of the five 20-min periods. At the mid-point of each urine collection, blood samples were taken for measurement of renal excretory function (1 ml of arterial blood) (29) and blood gas status (0.5 ml each of arterial and renal venous blood). Blood samples were replaced with washed red blood cells from previous samples and/or donor rabbit blood. Hematocrit fell slightly, from 31.2 Ϯ 0.5 to 29.9 Ϯ 0.5%, over the course of the experiment. ). The order of presentation of the infusions was randomized. In all experiments, the effects of angiotensin II and acetylcholine rapidly reversed when the infusion was replaced with the saline vehicle. Nevertheless, Ն30 min were allowed for stabilization of responses to angiotensin II or acetylcholine and for recovery from their effects before the clearance periods commenced. Blood and urine samples were collected as described for protocol 1. Hematocrit fell slightly, from 36.6 Ϯ 0.7 to 35.7 Ϯ 0.7%, over the course of the experiment.
Protocol 3: Reduced RAP
Protocol 3 (n ϭ 6) consisted of a series of nine 15-min clearance periods. After a control period, the renin-angiotensin system was "clamped" (7): administration of the angiotensin-converting enzyme inhibitor enalaprilat (2 mg/kg plus 10 g·kg Ϫ1 ·min Ϫ1 iv for the rest of the experiment) was followed 10 min later by an infusion of angiotensin II (6 -40 ng·kg Ϫ1 ·min Ϫ1 iv), titrated to restore mean arterial pressure (MAP) to its control level, which continued for the rest of the experiment. Once MAP and RBF had been stable for 10 min, a second 15-min clearance period began. RAP was then set randomly at 80, 70, 60, 50, 40, 30, or 20 mmHg. Once RAP had been stable for 5 min, a 15-min clearance period began. RAP was then set (randomly) at another of the seven nominal levels. Blood and urine samples were collected as described for protocols 1 and 2. Hematocrit fell slightly, from 37.4 Ϯ 0.9 to 36.3 Ϯ 1.3%, over the course of the experiment.
Statistics
Values were averaged over the entire 15 min of the urine collection periods or over the final 30 s of the 3-min periods of RNS. Data are expressed as means Ϯ SE and were analyzed by repeated-measures ANOVA (35) using the software package SYSTAT (version 10, SPSS, Chicago, IL) and by paired t-test using Microsoft Excel. Type 1 error was controlled with a Greenhouse-Geisser correction (35) . Two-sided P Յ 0.05 was considered statistically significant.
For protocol 1, we tested the hypothesis that RNS had stimulation frequency-dependent effects by analysis of variables during the control period and during RNS at 0.5, 1, and 2 Hz (repeated-measures ANOVA, P Freq). For protocol 2, we tested the hypothesis that the effects of angiotensin II and acetylcholine differed from those of saline (paired t-test, P ANG II and PACh). For protocol 3, we tested for effects of the renin-angiotensin system clamp (paired t-test, PClamp), whether the levels of the various variables were dependent on RAP (repeated-measures ANOVA, P RAP), and the threshold at which reduced RAP first significantly altered each variable (paired t-test).
RESULTS
Protocol 1: Electrical Stimulation of the Renal Nerves
RNS slightly increased MAP (ϩ4 Ϯ 1 mmHg at 2 Hz). At 2 Hz, RBF was reduced by Ϫ44 Ϯ 4% and was further reduced at 4 Hz (Ϫ85 Ϯ 5%) and 8 Hz (Ϫ93 Ϯ 4%). Cortical tissue PO 2 was not significantly altered by RNS at Յ2 Hz (Table 1 ). There was also no evidence of transient reductions in cortical tissue PO 2 during the initiation of RNS at these low frequencies. However, RNS at 4 and 8 Hz reduced cortical PO 2 by Ϫ16 Ϯ 5 mmHg (Ϫ55 Ϯ 10%) and Ϫ21 Ϯ 5 mmHg (Ϫ71 Ϯ 12%), respectively (data not shown). GFR, filtration fraction, fractional sodium excretion, and total sodium reabsorption were reduced by RNS. At 2 Hz, GFR was reduced from its control level of 3.37 Ϯ 0.57 to 0.85 Ϯ 0.17 ml/min, filtration fraction was reduced from 17.6 Ϯ 2.8 to 8.0 Ϯ 1.3%, and sodium reabsorption was reduced from 478 Ϯ 83 to 126 Ϯ 25 mol/ min (Table 1) .
Arterial blood PO 2 was not significantly altered by RNS, but renal venous PO 2 fell (by Ϫ6 Ϯ 2 mmHg at 2 Hz). RNS also increased the renal A-V oxygen concentration difference and fractional oxygen extraction. At 2-Hz RNS, the A-V oxygen concentration difference had increased from its control level of 1.59 Ϯ 0.21 to 2.04 Ϯ 0.27 ml O 2 /dl, while fractional oxygen extraction had increased from 12.0 Ϯ 1.5 to 16.5 Ϯ 2.1% ( Table 1) . RNS reduced renal Ḋ O 2 (Ϫ49 Ϯ 4% at 2 Hz) more than V O 2 (Ϫ30 Ϯ 7% at 2 Hz). RNS at 2 Hz also reduced the quotient of sodium reabsorption to V O 2 (renal energy efficiency quotient) by Ͼ50%, although this variable was little affected by RNS at 0.5 or 1 Hz (Table 1) .
Rabbits subjected to RNS were hypocapnic (19.1 Ϯ 1.4 mmHg arterial PCO 2 ), as reported in our previous study of the effects of angiotensin II (16.5 Ϯ 1.9 mmHg) (29) . There was no significant A-V gradient in PCO 2 ; renal venous PCO 2 averaged 19.1 Ϯ 1.2 mmHg. Renal venous pH (7.53 Ϯ 0.03 units) was 0.04 Ϯ 0.01 unit greater than arterial pH. RNS did not significantly affect arterial or venous PCO 2 or pH or the A-V gradients of these variables.
During the recovery period after RNS, no variables (Table  1) , including arterial and venous blood PCO 2 and pH (data not shown), differed significantly from their baseline level prior to initiation of RNS.
Protocol 2: Renal Arterial Infusion of Angiotensin II and Acetylcholine
Angiotensin II infusion did not significantly alter MAP. Angiotensin II reduced RBF by Ϫ37 Ϯ 3% but did not significantly alter cortical tissue PO 2 , which averaged 27.8 Ϯ 4.0 mmHg during saline infusion and 28.1 Ϯ 3.8 mmHg during infusion of angiotensin II (Table 2) . Angiotensin II reduced Values are means Ϯ SE (n ϭ 15). Baseline, levels during the initial 15-min urine collection period, prior to initiation of renal nerve stimulation, (RNS); PFreq, outcome of repeated-measures ANOVA, testing for a frequency-dependent effect of RNS; MAP, mean arterial pressure; RBF, renal blood flow; GFR, gomenular filtration rate; Ḋ O2, oxygen delivery; V O2, oxygen consumption; A-V, arterial-venous.
GFR from 3.32 Ϯ 0.31 to 2.62 Ϯ 0.27 ml/min, but the magnitude of this effect (Ϫ20 Ϯ 8%) was less than the reduction in RBF, so filtration fraction increased from 22.4 Ϯ 2.6 to 27.1 Ϯ 2.7% (Table 2 ). Total sodium reabsorption was reduced by Ϫ19 Ϯ 9% (Table 2) . Arterial blood PO 2 was little affected by angiotensin II, but renal venous blood PO 2 fell from 67.4 Ϯ 2.2 to 56.2 Ϯ 1.4 mmHg. The A-V oxygen concentration difference increased from 2.15 Ϯ 0.14 to 3.63 Ϯ 0.25 ml O 2 /dl, and fractional oxygen extraction increased from 12.6 Ϯ 0.8 to 21.7 Ϯ 1.4% (Table 2) . Angiotensin II reduced renal Ḋ O 2 (Ϫ38 Ϯ 3%) but not V O 2 . The quotient of sodium reabsorption to V O 2 was reduced from 19.4 Ϯ 1.7 to 14.4 Ϯ 1.5 mmol Na ϩ /mmol O 2 ( Table 2) . Acetylcholine infusion did not significantly alter MAP but increased RBF, GFR, and sodium reabsorption. Arterial blood PO 2 was little affected by acetylcholine, but renal venous blood PO 2 increased and fractional oxygen extraction fell. Acetylcholine significantly increased renal Ḋ O 2 but not V O 2 . Cortical tissue PO 2 was not significantly altered by acetylcholine infusion (Table 2) .
Rabbits in this protocol were normocapnic (38.8 Ϯ 1.7 mmHg). There were significant A-V gradients of pH and PCO 2 , with renal venous PCO 2 (32.6 Ϯ 1.3 mmHg) averaging 6.2 Ϯ 0.8 mmHg less than arterial PCO 2 and renal venous pH (7.47 Ϯ 0.01 units) averaging 0.08 Ϯ 0.01 unit more than arterial pH. Angiotensin II did not significantly alter arterial blood PCO 2 or pH or the magnitude of the A-V gradients of PCO 2 or pH. Nevertheless, there was a small but significant increase in renal venous PCO 2 (ϩ1.8 Ϯ 0.8 mmHg, P ANG II ϭ 0.04) and a small decrease in renal venous pH (Ϫ0.03 Ϯ 0.01 units, P ANG II ϭ 0.003) during angiotensin II infusion. Acetylcholine infusion did not significantly alter arterial or renal venous PCO 2 or pH or the magnitudes of the A-V gradients of PCO 2 or pH.
Replacing the infusions of angiotensin II or acetylcholine with the saline vehicle resulted in a rapid return of RBF to its baseline level but no appreciable change in MAP and cortical tissue PO 2 .
Protocol 3: Reduced RAP
Renin-angiotensin system clamp. Enalaprilat reduced RAP (from 77 Ϯ 1 to 55 Ϯ 5 mmHg) and increased RBF (from 24.6 Ϯ 3.1 to 36.2 Ϯ 5.5 ml/min) and cortical perfusion (from 288 Ϯ 12 to 387 Ϯ 22 units). Subsequent intravenous infusion of angiotensin II returned these variables toward their control levels. Neither enalaprilat nor angiotensin II significantly altered medullary perfusion or tissue PO 2 in the cortex or medulla. Once equilibrium was reached, RAP was slightly (4 Ϯ 1 mmHg) but significantly (P Clamp ϭ 0.03) greater than under control conditions (Table 3) . However, all other variables shown in Table 3 were indistinguishable from their control level.
Reductions in RAP. Reducing RAP progressively from 80 to 20 mmHg led to reductions in RBF that were statistically significant at Յ40 mmHg. Consistent with our previous findings in anesthetized rabbits (15) , this response was regionally heterogeneous, with significant reductions in outer cortical perfusion at Յ70 mmHg but no significant reduction in medullary perfusion until RAP was lowered to 20 mmHg (Table 3) . Cortical tissue PO 2 measured by fluorescence optode or Clark electrode and medullary tissue PO 2 measured by fluorescence optode were also not significantly reduced until RAP was reduced to 20 mmHg (Table 3) . GFR and sodium reabsorption were progressively reduced as RAP was reduced below 70 mmHg, while filtration fraction was significantly reduced once RAP was reduced to 50 mmHg (Table 3) .
Arterial blood PO 2 did not vary with RAP. Renal venous blood PO 2 only fell significantly when RAP reached 20 mmHg. Similarly, renal A-V oxygen concentration difference and fractional oxygen extraction remained relatively constant until RAP was reduced to 20 mmHg, at which point they increased markedly (Table 3) . Renal Ḋ O 2 fell significantly once RAP was reduced to Յ40 mmHg, in proportion to the reduction in RBF. In contrast, renal V O 2 fell in proportion to the reductions in GFR and sodium reabsorption, so a significant reduction in V O 2 was observed once RAP reached 60 mmHg. Consequently, reductions in V O 2 exceeded those in Ḋ O 2 until RAP fell to Յ30 mmHg (Table 3) . Thus, whereas Ḋ O 2 fell more than V O 2 during RNS and angiotensin II infusion, reductions in RAP reduced V O 2 more than Ḋ O 2 . As was the case with RNS and angiotensin II infusion, the quotient of sodium reabsorption to V O 2 was reduced as RAP fell to Յ40 mmHg (Table 3) .
PCO 2 of rabbits in this protocol was in the normocapnic range (36.2 Ϯ 1.1 mmHg), while arterial blood pH was 7.40 Ϯ Values are means Ϯ SE (n ϭ 12). Baseline, levels during renal arterial infusion of a saline vehicle; PANG II and PACh, outcomes of paired t-tests, testing for differences between periods of infusion of angiotensin II (ANG II) and acetylcholine (ACh) compared with the period of vehicle infusion. 0.02 units. There were significant A-V gradients of pH and PCO 2 , with renal venous PCO 2 averaging 3.8 Ϯ 1.5 mmHg less than arterial PCO 2 and renal venous pH averaging 0.06 Ϯ 0.01 unit more than arterial pH. Progressive reductions in RAP did not significantly alter arterial or venous blood PCO 2 or pH or the magnitude of the A-V gradients of PCO 2 or pH.
Table 3. Responses to clamping the renin-angiotensin system and subsequent graded reductions in RAP
At the completion of the experimental protocol, the suprarenal aortic cuff was deflated. In all six rabbits, this resulted in a rapid return of RAP, RBF, cortical and medullary perfusion, and cortical and medullary tissue PO 2 to their baseline levels.
Relationships Between Sodium Reabsorption and V O 2
When the data from all stimuli are considered together, a general trend is seen for reductions in sodium reabsorption to be associated with reductions in renal V O 2 . However, in all cases, the reductions in V O 2 were proportionally less than the reductions in sodium reabsorption (Fig. 1) .
DISCUSSION
Our findings indicate that the dynamic regulation of intrarenal oxygenation, in the face of renal vasoconstriction, is not achieved solely through the matching of changes in oxygen supply and demand by the "flow dependence" of renal V O 2 . As we showed previously (29, 39) , renal cortical tissue PO 2 was maintained relatively constant in the face of moderate ischemia induced by RNS or renal arterial infusion of angiotensin II. Renal tissue PO 2 was also relatively well maintained in the face of reduced RAP. However, beyond a critical degree of ischemia, as occurs during RNS at Ն4 Hz (present study), when RAP is reduced below the point where glomerular filtration ceases (present study), or during severe ischemia induced by angiotensin II (39), renal tissue PO 2 falls dramatically. Thus our finding of stable cortical tissue PO 2 during moderate renal ischemia cannot be explained through potential limitations of our technique for measuring tissue PO 2 . Indeed, this finding can be generalized across multiple species, multiple vasoconstrictor factors, and multiple methods for measurement of tissue PO 2 (29, 39) .
Our experiments addressed the mechanisms underlying maintenance of renal oxygenation during moderate renal ischemia. They show that the so-called flow dependence of renal V O 2 can explain maintenance of relatively stable renal tissue PO 2 during moderate renal ischemia induced by reduced RAP. However, the stability of cortical tissue PO 2 during RNS and angiotensin II infusion cannot be explained solely by this mechanism. We can also exclude a contribution of increased efficiency of renal oxygen utilization, since the quotient of sodium reabsorption to V O 2 decreased during all three ischemic stimuli. Taken together, our observations indicate that the kidney is able to extract a greater proportion of the oxygen delivered to it during ischemia induced by renal vasoconstriction and a lesser proportion during hyperemia induced by renal arterial infusion of acetylcholine, even in the absence of changes in tissue PO 2 .
The progressive reduction in the quotient of sodium reabsorption to V O 2 during renal ischemia does not necessarily reflect reduced efficiency of tubular oxygen utilization for sodium reabsorption per se. Instead, it likely reflects a lack of effect of ischemia on the quantity of oxygen that the kidney consumes for processes other than sodium reabsorption. Consequently, as sodium reabsorption is reduced, this "basal" renal metabolic work becomes a greater proportion of total V O 2 . Thus, as shown in Fig. 1 , ischemia reduces the numerator (sodium reabsorption) proportionally more than the denominator (V O 2 ). Nevertheless, the fact that angiotensin II infusion reduced sodium reabsorption without reducing V O 2 could potentially reflect a direct action on the efficiency of oxygen utilization for sodium reabsorption. Angiotensin II can increase generation of superoxide and, so, reduce the bioavailability of nitric oxide (16) . In turn, reduced nitric oxide bioavailability can reduce the efficiency of mitochondrial oxygen utilization (4).
The finding that kidney oxygen extraction increases during renal vasoconstriction (and decreases during renal vasodilatation) is at odds with the concept that homeostasis of intrarenal oxygenation, in the face of changes in RBF, is mediated virtually exclusively by the flow dependence of renal V O 2 . This concept has remained unchallenged for over five decades. It stems from the seminal studies of Van Slyke (42), Sanford Levy (34), Mathew , and colleagues, who showed that the fractional extraction of oxygen across the kidney remains relatively stable as RBF is reduced by reduced RAP. Their observations have been confirmed recently by others (40) and in our present study. Renal tissue PO 2 was well maintained as RAP was reduced from 80 to 40 mmHg. Across this pressure range, GFR was less well autoregulated than was RBF, as evidenced by a reduction in filtration fraction from 22.3 Ϯ 2.2 to 2.4 Ϯ 0.5%. Consequently, sodium reabsorption and, so, renal V O 2 were reduced proportionally more than were RBF and Ḋ O 2 . At 40 mmHg, sodium reabsorption was almost abolished (Ϫ90 Ϯ 3% of its baseline level), so the ability of V O 2 to decrease with further reductions in RAP was limited. Consequently, the marked reduction in Ḋ O 2 at 20 mmHg (Ϫ75 Ϯ 2% compared with baseline) exceeded the reduction in V O 2 (Ϫ53 Ϯ 5%) and, therefore, was accompanied by tissue hypoxia. Thus, in agreement with conventional wisdom, tissue PO 2 was well maintained as RAP was reduced, provided the deficit in Ḋ O 2 was matched with an equal or greater reduction in V O 2 .
In contrast to the situation during ischemia induced by acute renal hypotension, our findings indicate that the flow dependence of V O 2 is not the only mechanism operating to maintain stable tissue PO 2 during RNS. RNS at 2 Hz was associated with a 44% reduction in RBF and a 49% reduction in renal Ḋ O 2 . Renal V O 2 fell by 30%, likely secondary to a marked (73%) Fig. 1 . Relationships between sodium reabsorption and renal oxygen consumption. Separate plots are shown for renal ischemia induced by electrical stimulation of the renal nerves (RNS), renal arterial infusion of angiotensin II, and progressive reductions in renal artery pressure (RAP) and hyperemia induced by renal arterial infusion of acetylcholine. Data are derived from those presented in Tables 1-3. reduction in GFR associated with a fall in filtration fraction from 17.6 to 8.0%. Thus, in the case of RNS at Յ2 Hz, the reductions in renal oxygen demand were less than the reductions in oxygen supply, yet there was no evidence of renal tissue hypoxia.
Renal arterial infusion of angiotensin II was accompanied by a reduction in RBF (37%) of similar magnitude to that induced by 2-Hz RNS and a 38% reduction in Ḋ O 2 . However, renal V O 2 did not fall during infusion of angiotensin II, in part because filtration fraction increased from 22.4 to 27.2% so that GFR fell by only 20%. Nevertheless, cortical tissue PO 2 remained remarkably stable during angiotensin II-induced ischemia, despite the complete mismatch between changes in oxygen supply and demand. Similarly, cortical tissue PO 2 did not increase during renal arterial infusion of acetylcholine, even though Ḋ O 2 increased by 34% and V O 2 did not significantly change.
Homeostasis of renal oxygenation was achieved during RNS and angiotensin II infusion, despite a marked increase in fractional oxygen extraction, which increased from 12.6 to 21.7% during angiotensin II infusion and from 12.0 to 16.5% during 2-Hz RNS. However, these observations leave us with a conundrum. How does fractional oxygen extraction increase in the absence of reductions in tissue PO 2 ? This could occur if the surface area for oxygen diffusion increases (e.g., by capillary recruitment), but this is unlikely during ischemia. It could also occur if the PO 2 of blood in the small arteries and capillaries that supply the tissue with oxygen increases (24) , which could occur through operation of a local renal Bohr effect and/or through decreased renal A-V oxygen shunting (25) .
The Bohr effect refers to the ability of hydrogen ions to reduce the affinity of hemoglobin for oxygen (23) . Acidification of peritubular capillary blood should therefore lead to increased renal oxygen extraction. Ischemia should reduce the washout of carbon dioxide from the kidney, which could lead to acidification of blood in vessels supplying renal tissue with oxygen (18, 25) . On the other hand, metabolic carbon dioxide production will fall when V O 2 is reduced, which should lead to reduced tissue and peritubular blood PCO 2 (1, 9). We do not report measurements of cortical tissue PCO 2 or pH in the present study, but we did measure these variables in arterial and renal venous blood. Renal venous PCO 2 varies in parallel with peritubular capillary PCO 2 under a range of experimental conditions and, so, is a useful indirect measure of renal tissue PCO 2 (9, 18) , provided venous-to-arterial carbon dioxide shunting does not change (see below). Importantly, none of the ischemic or hyperemic stimuli we studied significantly altered the gradients of PCO 2 or pH across the renal circulation. This was the case under normocapnic (angiotensin II, acetylcholine, and reduced RAP in the present study) and hypocapnic [RNS in the present study and angiotensin II and acetylcholine in our previous study (29) ] conditions. Thus the prevailing level of arterial PCO 2 appears to have little impact on the potential for renal ischemia or hyperemia to alter renal carbon dioxide washout. It also has little impact on the ability of the kidney to maintain stable cortical tissue PO 2 in the face of changes in RBF within the physiological range. There was a small increase in renal venous PCO 2 (ϩ1.8 mmHg) and a small reduction in renal venous pH (Ϫ0.03 unit) during angiotensin II infusion in the present study, indicative of some increase in renal tissue/peritubular capillary PCO 2 . However, such small changes in renal venous PCO 2 The Bohr effect could also come into play during renal ischemia as a result of increased countercurrent exchange of carbon dioxide between venous and arterial vessels in the kidney and, so, the trapping of carbon dioxide in the renal cortex (12) . Mathematical models predict that carbon dioxide diffuses from veins to arteries in the kidney, elevating PCO 2 within the renal cortex (12) . They also predict that reduced RBF should enhance shunting of carbon dioxide from veins to arteries in the kidney due to the prolonged transit time of this gas in the circulation (2, 3, 12, 25) . The resultant decrease in blood pH within the renal cortex would be expected to reduce the affinity of hemoglobin for oxygen and, so, enhance Ḋ O 2 to tissue. Changes in renal tissue PCO 2 resulting from altered carbon dioxide shunting would not be detected from measurements of renal venous PCO 2 and, so, would need to be assessed by direct measurement. Previous experimental studies failed to demonstrate increased cortical PCO 2 during renal ischemia induced by aortic constriction, but interpretation of these experiments is limited by the fact that this stimulus reduces both RBF and V O 2 (9, 13, 18) . We did attempt to measure changes in tissue pH during renal arterial infusion of angiotensin II (unpublished observations), which does not reduce V O 2 , but available microelectrodes have a relatively unstable baseline, so precise measurements over the time scales required for such studies are problematic. Thus future studies employing improved methods for measurement of tissue PCO 2 and/or pH are warranted to fully explore the potential for the Bohr effect, induced by increased venous-to-arterial carbon dioxide shunting, to contribute to maintenance of tissue PO 2 during moderate renal ischemia.
Another mechanism that could potentially contribute to maintenance of tissue oxygenation during mild renal ischemia is decreased diffusional shunting of oxygen from arteries to veins. This phenomenon normally acts to reduce tissue PO 2 in the renal cortex (25, 38) . On theoretical grounds, a contribution of this mechanism seems unlikely, since the prolonged transit time of oxygen in the renal circulation, during renal ischemia, would be expected to enhance A-V oxygen shunting and, thereby, reduce renal tissue oxygen supply. However, as we argued recently, other factors could potentially limit diffusive oxygen shunting during renal ischemia and act to increase tissue PO 2 (17) . For example, if A-V oxygen diffusion equilibrium is reached at some point along the renal circulation, the quantity of oxygen shunted could decrease as RBF is reduced. Furthermore, increased vascular wall oxygen consumption during vasoconstriction could potentially limit A-V oxygen shunting. These considerations provide a rationale for further studies to dissect out the relative contributions of changes in A-V oxygen and carbon dioxide shunting to maintenance of tissue oxygenation during moderate renal ischemia.
Our observations of the responses of renal tissue PO 2 to ischemia induced by reduced RAP differ somewhat from those of a recent study by Warner and colleagues (43) . In their experiment in anesthetized pigs, RBF was reduced progressively (by reduction of RAP) under conditions of an intact renin-angiotensin system. In contrast, in our experiment in anesthetized rabbits, RAP was reduced to various levels in random order while the renin-angiotensin system was clamped to avoid the potentially confounding effects of its activation. In contradistinction to our present findings, Warner and colleagues observed reduced tissue PO 2 , in the cortex and medulla, during even relatively mild renal ischemia, even though V O 2 and Ḋ O 2 fell by a similar magnitude. The disparity in our findings could reflect species or methodological differences but, more likely, reflect the impact of the renin-angiotensin system, which makes a major contribution to autoregulation of GFR through the ability of angiotensin II to increase postglomerular vascular resistance (21) . Consequently GFR, sodium reabsorption, and, thus, V O 2 fell more markedly in the face of reduced RBF in our experiment than in the experiment of Warner and colleagues, which likely protected the rabbit kidney from development of tissue hypoxia. The findings of Warner and colleagues show that the kidney is susceptible to development of hypoxia during ischemia. The significance of our present findings is that they show that such susceptibility remains, even though multiple mechanisms act to maintain renal oxygenation during ischemia.
Under the experimental conditions we employed in the present study, renal V O 2 was ϳ50% of its baseline level when RAP was reduced to a level that abolished glomerular filtration. That is, approximately half of the oxygen consumed by the kidney under resting conditions was utilized for sodium reabsorption. This estimate differs to some degree from estimates of most previous in vivo studies in which the V O 2 of the filtering kidney was compared with that of the nonfiltering kidney (60 -80%) (20, 28) . This apparent discrepancy likely reflects the slightly volume-expanded status of our anesthetized rabbit preparation, in which only 90 -95% of the filtered load of sodium is reabsorbed, so that oxygen utilization for sodium reabsorption is already somewhat inhibited.
In protocol 3, cortical tissue PO 2 measured by fluorescence optode was markedly less than that measured by Clark electrode. We documented this phenomenon previously by showing that values of cortical tissue PO 2 obtained by these two methods differ by a fixed proportion (30) . We also argued previously that, for various technical reasons, Clark electrodes may slightly overestimate cortical tissue PO 2 while fluorescence optodes may underestimate it, so the true value of cortical tissue PO 2 is likely somewhere between the values obtained by the two methods (30) . Because of the potential for the thicker fluorescence optodes to induce much greater tissue damage than fine Clarke microelectrodes, we speculate that the true value probably lies closer to that provided by the Clark electrode. Regardless, as demonstrated in protocol 3 and in our previous reports (29, 30, 39) , both methods are equally capable of detecting changes in tissue PO 2 .
Conclusion
The development of tissue hypoxia in pathological conditions has been thought to result from the development of mismatches between renal Ḋ O 2 and tissue oxygen demand (37) . However, our present findings show clearly that, under some conditions, the kidney is able to avoid tissue hypoxia, even when changes in Ḋ O 2 and O 2 demand are mismatched. The ability of the kidney to extract a greater proportion of the delivered oxygen during ischemia in the absence of reduced tissue PO 2 could rely partly on the ability of renal ischemia to alter diffusive shunting of carbon dioxide from veins to arteries, or even shunting of oxygen from arteries to veins. Dysfunction of these mechanisms could plausibly predispose the kidney to hypoxic injury during periods of moderate renal ischemia.
